Stockholm, Sweden

Mats Dahlberg

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mats Dahlberg: Innovator in Polypeptide Research

Introduction

Mats Dahlberg is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of novel polypeptides and their applications in medicine. With a total of 2 patents, Dahlberg's work has the potential to impact various therapeutic areas.

Latest Patents

Dahlberg's latest patents include groundbreaking inventions related to nucleic acid encoding vitamin D receptor related polypeptides. This invention encompasses novel vitamin D receptor related (VDRR) polypeptides and formulations containing them. It also details nucleic acid sequences encoding the VDRR polypeptides, expression vectors, and host cells transformed with these vectors. Furthermore, the invention outlines methods for expressing the VDRR polypeptides and their use as medicaments for treating metabolic, proliferative, or inflammatory conditions. Another significant patent involves the human p21-activated kinase 5 polypeptide, which identifies and encodes P-activated kinase (PAK) polynucleotides. This invention provides expression vectors, host cells, and methods for production, as well as methods for identifying PAK agonists and antagonists for treating human diseases.

Career Highlights

Throughout his career, Mats Dahlberg has worked with prominent companies such as Pfizer Corporation and Pharmacia Italia S.p.a. His experience in these organizations has contributed to his expertise in the field of biotechnology and polypeptide research.

Collaborations

Dahlberg has collaborated with notable professionals in his field, including Anders Berkenstam and Jurgen Moll. These collaborations have likely enriched his research and development efforts.

Conclusion

Mats Dahlberg is a distinguished inventor whose work in polypeptide research holds promise for advancing medical treatments. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…